The Valley Hospital is proud to announce the availability of PET scanning at The Robert and Audrey Luckow Pavilion in Paramus. PET, or Positron Emission Tomography, is a lifesaving molecular imaging technology that is unsurpassed in the diagnosis and staging of some cancers, as well as the diagnosis of heart disease, Alzheimer’s and other neurological diseases.
"We are thrilled to offer this exceptional technology to our Valley Hospital communities," said Audrey Meyers, president of The Valley Hospital. "We believe it will pinpoint critical information about diseases faced by our patients, and in turn enable them to get the best possible care, which is always a goal in everything we do."
"Currently, most members of our immediate community come to Valley for MRIs, CAT scans and other imaging services, but typically travel to New York City for PET. We expect patients and physicians alike to find PET scans at Valley’s Paramus facility much more convenient," Ms. Meyers added.
For a primer on PET scanning, click here. To learn about the technical specifications of Valley's PET Scanner, click here.
PET is making critical contributions to cancer care as well as in cardiology and neurology. Advantages of PET can include earlier diagnoses, identification of distant metastases, elimination of invasive procedures, avoidance of multiple tests, better assessment of chemotherapy effectiveness and more effective patient monitoring. PET is also an outstanding tool for assessing cardiac viability, as well as Alzheimer’s, Parkinson’s Disease and other neurological disorders.
For patients with cancer in remission, upon any possible signs of recurring disease, PET scans can determine whether cancer has returned to previously affected organs or anywhere in the patient’s body. Unlike MRIs and CAT scans, which produce still images of physical structures in the body, PET is revolutionary because it tracks actual metabolic processes and body function, which dramatically distinguish cancerous and other diseased tissue from normal functioning cells.
Specifically, glucose or other compounds treated with radioactive tracers are injected into the patient’s body. The PET scan provides a clear picture of how some body organs use these compounds and in turn allows for the design of optimum treatment for many diseases. For example, since some cancerous tissues metabolize glucose at much higher rates than normal tissue, with a single scan, a PET scan may produce clear indications of cancerous tissue. For other diseases such as heart disease and Alzheimer’s, Parkinson’s or neurological disorders, PET similarly reflects actual metabolic processes, which provides an extraordinary depiction of normal or diseased functioning of organs.
"The use of PET scanning will allow Valley Hospital physicians to select the optimum treatment plan for their patients," said Philip Sorabella, M.D., Director of Nuclear Medicine at The Valley Hospital. "It’s a wonderful new tool and we are happy to have it be a part of our new Cancer Center services."